GO:0039532 negative regulation of cytoplasmic pattern recognition receptor signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0039532 describes any process that stops, prevents, or reduces the frequency, rate or extent of cytoplasmic pattern recognition receptor signaling [1, 5].
• Cytoplasmic pattern recognition receptors (PRRs) such as RIG-I, MDA5, and cGAS detect viral RNA and DNA in the cytosol and initiate antiviral interferon responses [4, 5].
• Negative regulation of these pathways is essential to prevent excessive inflammation and autoimmunity, and is mediated by proteins including optineurin, NLRX1, and A20 [2, 5].
• Dysregulation of this process is linked to autoimmune diseases, chronic inflammation, and cancer [3, 5].
• Key experimental approaches include knockout and knock-in cell models, CRISPR screening, and RNA-seq to dissect regulatory networks [1, 2].
• EDITGENE provides comprehensive CRISPR services to study GO:0039532, from gene knockout to overexpression and library screening.
Description
The innate immune system relies on pattern recognition receptors (PRRs) to detect conserved microbial components and initiate rapid defense responses [1, 6]. Among these, cytoplasmic PRRs such as RIG-I-like receptors (RLRs) and DNA sensors recognize viral nucleic acids in the cytosol, triggering signaling cascades that lead to type I interferon and pro-inflammatory cytokine production [4, 5]. While essential for host defense, unchecked activation of these pathways can cause tissue damage and autoimmune disease, necessitating tight negative regulation [3, 5]. GO:0039532, negative regulation of cytoplasmic pattern recognition receptor signaling pathway, encompasses the molecular mechanisms that restrain these cytosolic sensing cascades [1, 5]. Understanding this process is critical for researchers studying antiviral immunity, autoinflammation, and cancer immunology [2, 3].
negative regulation of cytoplasmic pattern recognition receptor signaling pathway At A Glance
| GO ID | GO:0039532 |
|---|---|
| GO term | negative regulation of cytoplasmic pattern recognition receptor signaling pathway |
| Ontology | biological_process |
| Synonym | negative regulation of MAVS signaling; negative regulation of cytosolic pattern recognition receptor signaling pathway; negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway |
| Major function | Suppression of cytosolic PRR signaling to prevent excessive inflammation and autoimmunity |
| Key regulators | Optineurin, NLRX1, A20, CYLD, and others [2, 5] |
| Associated diseases | Autoimmune diseases, chronic inflammation, cancer [3, 5] |
| Research methods | CRISPR knockout, knock-in, overexpression, RNA-seq, proteomics [1, 2] |
What Is GO:0039532?
GO:0039532 is a biological process term defined as any process that stops, prevents, or reduces the frequency, rate or extent of the series of a cytoplasmic pattern recognition receptor signaling pathway. In simpler terms, it includes all molecular events that put the brakes on cytosolic PRR signaling, preventing excessive or prolonged immune activation in response to viral or danger signals [1, 5].
Why Is negative regulation of cytoplasmic pattern recognition receptor signaling pathway Important in Cell Biology?
Negative regulation of cytoplasmic PRR signaling is crucial for maintaining immune homeostasis. Without proper control, cytosolic sensing of self-nucleic acids can lead to autoimmune conditions such as Aicardi-Goutières syndrome and systemic lupus erythematosus. Moreover, pathogens often exploit these negative regulators to evade immune detection, and cancer cells may dysregulate them to survive immune attack [3, 5]. Thus, understanding GO:0039532 provides insights into host-pathogen interactions, autoimmunity, and cancer immunotherapy [1, 2].
• Prevents autoimmunity by avoiding recognition of self-nucleic acids.
• Limits tissue damage from excessive inflammation during viral infections.
• Regulates the duration and magnitude of antiviral interferon responses.
• Pathogens can hijack negative regulators to evade innate immunity.
• Dysregulation is implicated in autoimmune diseases like lupus and Aicardi-Goutières syndrome.
• Modulates cancer immunosurveillance and response to immunotherapy.
• Provides targets for therapeutic intervention in inflammatory diseases.
• Essential for understanding cross-talk between PRR pathways.
• Key to developing CRISPR-based models for immune signaling research.
• Informs vaccine adjuvant design by modulating innate immune activation.
What Happens During negative regulation of cytoplasmic pattern recognition receptor signaling pathway?
Recognition of cytosolic PRR activation
In simple terms: The cell first detects that a cytoplasmic PRR pathway has been turned on.
Upon sensing viral RNA or DNA, cytoplasmic PRRs such as RIG-I and MDA5 undergo conformational changes and initiate signaling through MAVS and STING [4, 5]. Negative regulators are recruited or activated in response to these initial events to prevent overshooting [1, 5].
Recruitment of negative regulators
In simple terms: Brake proteins are brought to the signaling complex.
Proteins like optineurin, NLRX1, and A20 are recruited to the signaling platforms. For example, chicken optineurin suppresses MDA5-mediated interferon beta production by interacting with MDA5 and inhibiting its function. NLRX1 associates with MAVS to disrupt RLR-MAVS interaction.
Inhibition of signaling intermediates
In simple terms: The brake proteins block key steps in the pathway.
Negative regulators can deubiquitinate or degrade signaling molecules. A20 (TNFAIP3) removes K63-linked ubiquitin chains from TBK1 and IKKi, thereby terminating IRF3 activation [3, 5]. CYLD similarly deubiquitinates RIG-I and TBK1 to dampen interferon induction.
Termination of the response
In simple terms: The immune response is shut down to return to baseline.
Following inhibition, the signaling complex is disassembled, and activated transcription factors are degraded or inactivated. This prevents chronic interferon production and maintains immune tolerance [1, 5].
Key Genes Involved in GO:0039532 negative regulation of cytoplasmic pattern recognition receptor signaling pathway
The following genes and proteins are central to the negative regulation of cytoplasmic pattern recognition receptor signaling, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| OPTN | Inhibits MDA5-mediated interferon production | Target for antiviral and autoimmune studies |
| NLRX1 | Disrupts RLR-MAVS interaction | Modulator of antiviral immunity |
| TNFAIP3 (A20) | Deubiquitinates TBK1 and IKKi [3, 5] | Key regulator of NF-kB and IRF3 |
| CYLD | Deubiquitinates RIG-I and TBK1 | Tumor suppressor and immune regulator |
| MAVS | Central adaptor in RLR signaling; targeted by negative regulators | Core node for intervention |
| RIG-I (DDX58) | Cytosolic RNA sensor; subject to negative regulation | Antiviral sensor and drug target |
| MDA5 (IFIH1) | Cytosolic RNA sensor; inhibited by optineurin | Autoimmune disease association |
| cGAS (MB21D1) | Cytosolic DNA sensor; regulated by negative factors | DNA sensing and autoinflammation |
| STING (TMEM173) | Adaptor for DNA sensing; targeted by negative regulators | Therapeutic target in cancer |
| TBK1 | Kinase in PRR signaling; deubiquitinated by A20 | Central kinase for IRF3 activation |
| IKKi (IKBKE) | Kinase in PRR signaling; deubiquitinated by A20 | Interferon induction regulator |
| IRF3 | Transcription factor; inhibited by negative regulators | Key interferon response factor |
| NF-kB | Transcription factor; modulated by A20 and CYLD | Inflammation and immunity |
| TRIM25 | Ubiquitin ligase for RIG-I; counteracted by negative regulators | Modulates RIG-I activity |
| USP3 | Deubiquitinase that stabilizes negative regulators | Regulates innate immune signaling |
| PIN1 | Inhibits RIG-I-mediated signaling | Potential therapeutic target |
| SOCS1 | Suppresses interferon signaling | Cross-talk with PRR pathways |
How Is negative regulation of cytoplasmic pattern recognition receptor signaling pathway Regulated?
The negative regulation of cytoplasmic PRR signaling is itself tightly controlled. For instance, the expression of negative regulators like A20 and CYLD is induced by NF-kB, creating a negative feedback loop [3, 5]. Post-translational modifications, such as phosphorylation by MAP kinases, can modulate the activity of these regulators. Additionally, viral proteins can mimic or hijack cellular negative regulators to evade immunity [2, 5].
negative regulation of cytoplasmic pattern recognition receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TNFAIP3 (A20) | Autoimmunity, B-cell lymphoma [3, 5] | Knockout mice, cell lines |
| OPTN | Autoinflammation, antiviral response | Knockout and overexpression cells |
| NLRX1 | Inflammatory bowel disease, viral infection | Knockout mice, intestinal organoids |
| CYLD | Cylindromatosis, autoimmunity | Knockout and knock-in models |
| MAVS | Autoimmune interferonopathy | Point mutation knock-in mice |
Autoimmune and Autoinflammatory Diseases
Loss-of-function mutations in negative regulators of cytosolic PRR signaling lead to type I interferonopathies such as Aicardi-Goutières syndrome and systemic lupus erythematosus. For example, mutations in A20 are associated with early-onset autoimmunity. Similarly, dysregulation of optineurin has been linked to autoimmune conditions.
Cancer
Chronic activation of cytosolic PRR pathways can promote inflammation-driven tumorigenesis, while negative regulators may be downregulated in some cancers to enhance antitumor immunity. A20 is a tumor suppressor in B-cell lymphomas, and its loss leads to constitutive NF-kB activation [3, 5].
Infectious Diseases
Many viruses encode proteins that inhibit cytosolic PRR signaling to evade host defense. For instance, optineurin is targeted by viral factors to suppress interferon production. Understanding these interactions can inform antiviral strategies.
From negative regulation of cytoplasmic pattern recognition receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate RLR signaling? | CRISPR knockout cell line (e.g., HEK293T, THP-1) |
| How does a point mutation affect regulator function? | Point mutation knock-in via CRISPR |
| Where does the regulator localize during infection? | Tagged knock-in (e.g., GFP) cell line |
| Does overexpression of gene X suppress interferon? | Overexpression cell line |
| Which genes regulate cytosolic DNA sensing? | CRISPR library screening |
| What are the transcriptomic changes upon regulator loss? | RNA-seq of knockout cells |
How to Study the negative regulation of cytoplasmic pattern recognition receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotype | Identify negative regulators |
| CRISPR knock-in | Precise mutation or tag | Study point mutations or localization |
| RNA-seq | Transcriptome changes | Downstream effects of regulator loss |
| Proteomics | Protein interactions and modifications | Identify signaling complexes |
| Luciferase reporter | Pathway activity | Screen for inhibitors |
| Immunoblotting | Protein expression and phosphorylation | Validate signaling changes |
| Immunofluorescence | Subcellular localization | Track regulator recruitment |
| CRISPR library screening | Pooled gene function | Discover novel regulators |
CRISPR Knockout and Knock-in
CRISPR-Cas9 knockout of candidate negative regulators followed by viral infection or PRR stimulation can reveal their role in suppressing interferon and cytokine production [2, 5]. Knock-in of point mutations or tags allows precise functional studies.
RNA-seq and Transcriptomics
RNA sequencing of cells with perturbed negative regulators identifies downstream gene expression changes, including interferon-stimulated genes and inflammatory cytokines [1, 3].
Proteomics and Immunoprecipitation
Mass spectrometry-based proteomics can identify interaction partners of negative regulators and post-translational modifications that control their activity.
Imaging and Reporter Assays
Fluorescence microscopy and luciferase reporter assays for interferon-beta or NF-kB enable real-time monitoring of PRR signaling and its inhibition [2, 4].
How CRISPR Can Be Used to Study GO:0039532 negative regulation of cytoplasmic pattern recognition receptor signaling pathway
Knockout
CRISPR knockout of genes such as OPTN or TNFAIP3 in cell lines like THP-1 or HEK293T can confirm their role in negatively regulating cytosolic PRR signaling. Loss of these genes typically leads to enhanced interferon production upon viral infection [2, 5].
Point Mutation
Introducing disease-associated point mutations (e.g., in TNFAIP3) via CRISPR knock-in allows researchers to study how specific amino acid changes affect the ability to suppress PRR signaling [3, 5].
Knock-in
Tagging endogenous negative regulators with fluorescent proteins or epitope tags using CRISPR knock-in enables real-time imaging and biochemical analysis of their dynamics during infection.
Overexpression
Overexpression of candidate negative regulators using lentiviral or CRISPR activation systems can test whether increased levels are sufficient to dampen cytosolic PRR signaling and reduce interferon responses [2, 4].
How EDITGENE Supports negative regulation of cytoplasmic pattern recognition receptor signaling pathway Research
Researchers studying negative regulation of cytoplasmic pattern recognition receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in suppressing or modulating innate immune responses. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of cytoplasmic pattern recognition receptor signaling pathway research.
Frequently Asked Questions About negative regulation of cytoplasmic pattern recognition receptor signaling pathway
What is GO:0039532?
GO:0039532 is a Gene Ontology term for any process that stops, prevents, or reduces the frequency, rate or extent of cytoplasmic pattern recognition receptor signaling pathway [1, 5].
What genes are involved in negative regulation of cytoplasmic pattern recognition receptor signaling?
Key genes include OPTN, NLRX1, TNFAIP3 (A20), CYLD, and others that inhibit RLR or DNA sensing pathways [2, 3, 5].
Why is negative regulation of cytoplasmic PRR signaling important?
It prevents excessive inflammation and autoimmunity by keeping antiviral responses in check [3, 5].
What diseases are associated with defects in this pathway?
Autoimmune diseases like lupus and Aicardi-Goutières syndrome, as well as certain cancers, are linked to dysregulation [3, 5].
How can I study negative regulation of cytoplasmic PRR signaling?
CRISPR knockout, knock-in, overexpression, RNA-seq, and proteomics are common approaches [1, 2].
What is the role of optineurin in this process?
Optineurin suppresses MDA5-mediated interferon beta production, acting as a negative regulator.
How does A20 regulate cytoplasmic PRR signaling?
A20 deubiquitinates TBK1 and IKKi, terminating IRF3 activation and interferon production [3, 5].
Can viruses evade this negative regulation?
Yes, some viruses target negative regulators like optineurin to enhance their replication.
What CRISPR models are available for this pathway?
Knockout, point mutation knock-in, tagged knock-in, and overexpression models can be custom-generated [1, 2].
How does EDITGENE support research on GO:0039532?
EDITGENE offers CRISPR cell model generation, library screening, and bioinformatics services tailored to innate immunity [1, 2].
Conclusion
GO:0039532, negative regulation of cytoplasmic pattern recognition receptor signaling pathway, is a critical biological process that maintains immune balance by restraining cytosolic PRR signaling. Dysregulation of this pathway contributes to autoimmunity, chronic inflammation, and cancer, making it a vibrant area of research. Leveraging CRISPR-based models and advanced screening technologies will continue to uncover new regulatory mechanisms and therapeutic opportunities.
References
- 1. Arthur JS et al.. 2013. Mitogen-activated protein kinases in innate immunity.. Nat Rev Immunol 13(9):679-92 PMID: 23954936
- 2. Li Y et al.. 2021. Chicken optineurin suppresses MDA5-mediated interferon β production.. Poult Sci 100(1):9-18 PMID: 33357711
- 3. Leifer CA et al.. 2016. Molecular mechanisms of regulation of Toll-like receptor signaling.. J Leukoc Biol 100(5):927-941 PMID: 27343013
- 4. García M et al.. 2009. Regulation and function of the cytosolic viral RNA sensor RIG-I in pancreatic beta cells.. Biochim Biophys Acta 1793(11):1768-75 PMID: 19747951
- 5. Abe T et al.. 2019. Negative Regulation of Cytosolic Sensing of DNA.. Int Rev Cell Mol Biol 344:91-115 PMID: 30798991
- 6. Lee MS et al.. 2007. Signaling pathways downstream of pattern-recognition receptors and their cross talk.. Annu Rev Biochem 76:447-80 PMID: 17328678
